Connect with us

Spread & Containment

New UK biotech Inspira uncloaks with deal to develop inhaled COVID therapy

UK biotech Inspira Pharmaceuticals has emerged from stealth mode with a deal with Vectura to develop an inhaled
The post New UK biotech Inspira uncloaks with deal to develop inhaled COVID therapy appeared first on .

Published

on

UK biotech Inspira Pharmaceuticals has emerged from stealth mode with a deal with Vectura to develop an inhaled therapy for COVID-19 that could be ready for human testing within 12 months. 

The start-up is focusing on processed and purified extracts from an undisclosed plant source that have been shown in lab studies to kill the SARS-CoV-2 virus, and also have potential applications in other respiratory infections.

Rory McGoldrick

Even though vaccinations are promising to shift COVID-19 from a pandemic to an endemic disease, there will still be a need for new therapies that are “cost effective, easy to distribute and easy to administer,” according to Inspira chief executive Rory McGoldrick.

“We believe COVID-19 will be with us for years, probably decades, to come,” he told Pharmaphorum.

“We are targeting a treatment that has the potential to be effective at the early phase of infection, to minimise the risk of hospitalisation and reduce the need for ventilatory support in intensive care.”

Inspira’s plant extract platform – called IPX – has emerged from research conducted over the last five years at Queen Mary University in London.

The IPX formulations contain proteolytic enzymes that have shown to be effective in degrading biofilms that develop on the surface of the lung during infections and also target the spike protein on the SARS-CoV-2 virus.

The lead IPX candidate has been tested for the feasibility of delivery using Vectura’s FOX vibrating mesh nebuliser, and the next stage is to develop and make batches that are stable over extended periods and can be used to test safety and tolerability in animal studies.

“Inspira’s research is still at a very early stage, but from our very first meetings with Vectura, their team seemed to recognise the potential of our IPX technology and they have supported us brilliantly from day one,” said McGoldrick.

All studies will be undertaken at Vectura’s Chippenham, UK facility, and the aim is to be ready to start efficacy testing of the COVID-19 IPX formulation in the latter half of 2022.

“Seasonality will play a role, with winter being the ideal time to recruit patients,” said McGoldrick. “We won’t be ready this coming winter in the UK, but we are targeting mid-2022 (in the Southern Hemisphere) or UK winter 2022 for our first efficacy study.”

The London-based biotech has financed by founders and private investors to date with “a mountain of sweat-equity”, according to McGoldrick, and is in the process of a crowdfunding exercise on Crowdcube that aims to raise £350,000 to £500,000.

That will be used to complete the initial phases of Inspira’s formulation work with Vectura and complete the first round of animal safety testing. Before the end of the year, the company intends to go for another funding round – hopefully armed with positive safety and efficacy data in animals.

Inspira is also testing the virucidal response of its IPX formulations against the latest SARS-CoV-2 variants of concern, whilst carrying out additional research in other respiratory infections.

“One area of research we are particularly excited about is the ability of IPX formulations to degrade biofilms,” McGoldrick told us.

“Biofilms are a huge clinical challenge when they form in the lungs in connection with bacterial infections [and] they remain a key area of focus for global research efforts due to the limited treatment options available.”

The post New UK biotech Inspira uncloaks with deal to develop inhaled COVID therapy appeared first on .

Read More

Continue Reading

Spread & Containment

Study: Life’s building blocks are surprisingly stable in Venus-like conditions

If there is life in the solar system beyond Earth, it might be found in the clouds of Venus. In contrast to the planet’s blisteringly inhospitable surface,…

Published

on

If there is life in the solar system beyond Earth, it might be found in the clouds of Venus. In contrast to the planet’s blisteringly inhospitable surface, Venus’ cloud layer, which extends from 30 to 40 miles above the surface, hosts milder temperatures that could support some extreme forms of life. 

Credit: Credit: JAXA/J. J. Petkowski

If there is life in the solar system beyond Earth, it might be found in the clouds of Venus. In contrast to the planet’s blisteringly inhospitable surface, Venus’ cloud layer, which extends from 30 to 40 miles above the surface, hosts milder temperatures that could support some extreme forms of life. 

If it’s out there, scientists have assumed that any Venusian cloud inhabitant would look very different from life forms on Earth. That’s because the clouds themselves are made from highly toxic droplets of sulfuric acid — an intensely corrosive chemical that is known to dissolve metals and destroy most biological molecules on Earth. 

But a new study by MIT researchers may challenge that assumption. Appearing today in the journal Astrobiology, the study reports that, in fact, some key building blocks of life can persist in solutions of concentrated sulfuric acid. 

The study’s authors have found that 19 amino acids that are essential to life on Earth are stable for up to four weeks when placed in vials of sulfuric acid at concentrations similar to those in Venus’ clouds. In particular, they found that the molecular “backbone” of all 19 amino acids remained intact in sulfuric acid solutions ranging in concentration from 81 to 98 percent.  

“What is absolutely surprising is that concentrated sulfuric acid is not a solvent that is universally hostile to organic chemistry,” says study co-author Janusz Petkowski, a research affiliate in MIT’s Department of Earth, Atmospheric and Planetary Sciences (EAPS).

“We are finding that building blocks of life on Earth are stable in sulfuric acid, and this is very intriguing for the idea of the possibility of life on Venus,” adds study author Sara Seager, MIT’s Class of 1941 Professor of Planetary Sciences in EAPS and a professor in the departments of Physics and of Aeronautics and Astronautics. “It doesn’t mean that life there will be the same as here. In fact, we know it can’t be. But this work advances the notion that Venus’ clouds could support complex chemicals needed for life.”

The study’s co-authors include first author Maxwell Seager, an undergraduate in the Department of Chemistry at Worcester Polytechnic Institute and Seager’s son, and William Bains, a research affiliate at MIT and a scientist at Cardiff University.

Building blocks in acid

The search for life in Venus’ clouds has gained momentum in recent years, spurred in part by a controversial detection of phosphine — a molecule that is considered to be one signature of life — in the planet’s atmosphere. While that detection remains under debate, the news has reinvigorated an old question: Could Earth’s sister planet actually host life? 

In search of an answer, scientists are planning several missions to Venus, including the first largely privately funded mission to the planet, backed by California-based launch company Rocket Lab. That mission, on which Seager is the science principal investigator, aims to send a spacecraft through the planet’s clouds to analyze their chemistry for signs of organic molecules. 

Ahead of the mission’s January 2025 launch, Seager and her colleagues have been testing various molecules in concentrated sulfuric acid to see what fragments of life on Earth might also be stable in Venus’ clouds, which are estimated to be orders of magnitude more acidic than the most acidic places on Earth.

“People have this perception that concentrated sulfuric acid is an extremely aggressive solvent that will chop everything to pieces,” Petkowski says. “But we are finding this is not necessarily true.”

In fact, the team has previously shown that complex organic molecules such as some fatty acids and nucleic acids remain surprisingly stable in sulfuric acid. The scientists are careful to emphasize, as they do in their current paper, that “complex organic chemistry is of course not life, but there is no life without it.” 

In other words, if certain molecules can persist in sulfuric acid, then perhaps the highly acidic clouds of Venus are habitable, if not necessarily inhabited. 

In their new study, the team turned their focus on amino acids — molecules that combine  to make essential proteins, each with their own specific function. Every living thing on Earth requires amino acids to make proteins that in turn carry out life-sustaining functions, from breaking down food to generating energy, building muscle, and repairing tissue. 

“If you consider the four major building blocks of life as nucleic acid bases, amino acids, fatty acids, and carbohydrates, we have demonstrated that some fatty acids can form micelles and vesicles in sulfuric acid, and the nucleic acid bases are stable in sulfuric acid. Carbohydrates have been shown to be highly reactive in sulfuric acid,” Maxwell
Seager explains. “That only left us with amino acids as the last major building block to
study.”

A stable backbone

The scientists began their studies of sulfuric acid during the pandemic, carrying out their experiments in a home laboratory. Since that time, Seager and her son continued work on chemistry in concentrated sulfuric acid. In early 2023, they ordered powder samples of 20 “biogenic” amino acids — those amino acids that are essential to all life on Earth. They dissolved each type of amino acid in vials of sulfuric acid mixed with water, at concentrations of 81 and 98 percent, which represent the range that exists in Venus’ clouds. 

The team then let the vials incubate for a day before transporting them to MIT’s Department of Chemistry Instrumentation Facility (DCIF), a shared, 24/7 laboratory that offers a number of automated and manual instruments for MIT scientists to use. For their part, Seager and her team used the lab’s nuclear magnetic resonance (NMR) spectrometer to analyze the structure of amino acids in sulfuric acid. 

After analyzing each vial several times over four weeks, the scientists found, to their surprise, that the basic molecular structure, or “backbone” in 19 of the 20 amino acids remained stable and unchanged, even in highly acidic conditions.

“Just showing that this backbone is stable in sulfuric acid doesn’t mean there is life on Venus,” notes Maxwell Seager. “But if we had shown that this backbone was compromised, then there would be no chance of life as we know it.” 

The team acknowledges that Venus’ cloud chemistry is likely messier than the study’s “test tube” conditions. For instance, scientists have measured various trace gases, in addition to sulfuric acid, in the planet’s clouds. As such, the team plans to incorporate certain trace gases in future experiments. 

“There are only a few groups in the world now that are working on chemistry in sulfuric acid, and they will all agree that no one has intuition,” adds Sara Seager. “I think we are just more happy than anything that this latest result adds one more ‘yes’ for the possibility of life on Venus.”

###

Written by Jennifer Chu, MIT News

Paper: “Stability of 20 Biogenic Amino Acids in Concentrated Sulfuric Acid: Implications for the Habitability of Venus’ Clouds”

https://www.liebertpub.com/doi/10.1089/ast.2023.0082


Read More

Continue Reading

Spread & Containment

Bacteria subtype linked to growth in up to 50% of human colorectal cancers, Fred Hutch researchers report

Researchers at Fred Hutchinson Cancer Center have found that a specific subtype of a microbe commonly found in the mouth is able to travel to the gut and…

Published

on

Researchers at Fred Hutchinson Cancer Center have found that a specific subtype of a microbe commonly found in the mouth is able to travel to the gut and grow within colorectal cancer tumors. This microbe is also a culprit for driving cancer progression and leads to poorer patient outcomes after cancer treatment.

Credit: Fred Hutchinson Cancer Center

Researchers at Fred Hutchinson Cancer Center have found that a specific subtype of a microbe commonly found in the mouth is able to travel to the gut and grow within colorectal cancer tumors. This microbe is also a culprit for driving cancer progression and leads to poorer patient outcomes after cancer treatment.

The findings, published March 20 in the journal Nature, could help improve therapeutic approaches and early screening methods for colorectal cancer, which is the second most common cause of cancer deaths in adults in the U.S. according to the American Cancer Society.

Examining colorectal cancer tumors removed from 200 patients, the Fred Hutch team measured levels of Fusobacterium nucleatum, a bacterium known to infect tumors. In about 50% of the cases, they found that only a specific subtype of the bacterium was elevated in the tumor tissue compared to healthy tissue.

The researchers also found this microbe in higher numbers within stool samples of colorectal cancer patients compared with stool samples from healthy people.

“We’ve consistently seen that patients with colorectal tumors containing Fusobacterium nucleatum have poor survival and poorer prognosis compared with patients without the microbe,” explained Susan Bullman, Ph.D., Fred Hutch cancer microbiome researcher and co-corresponding study author. “Now we’re finding that a specific subtype of this microbe is responsible for tumor growth. It suggests therapeutics and screening that target this subgroup within the microbiota would help people who are at a higher risk for more aggressive colorectal cancer.”

In the study, Bullman and co-corresponding author Christopher D. Johnston, Ph.D., Fred Hutch molecular microbiologist, along with the study’s first author Martha Zepeda-Rivera, Ph.D., a Washington Research Foundation Fellow and Staff Scientist in the Johnston Lab, wanted to discover how the microbe moves from its typical environment of the mouth to a distant site in the lower gut and how it contributes to cancer growth.

First they found a surprise that could be important for future treatments. The predominant group of Fusobacterium nucleatum in colorectal cancer tumors, thought to be a single subspecies, is actually composed of two distinct lineages known as “clades.”

“This discovery was similar to stumbling upon the Rosetta Stone in terms of genetics,” Johnston explained. “We have bacterial strains that are so phylogenetically close that we thought of them as the same thing, but now we see an enormous difference between their relative abundance in tumors versus the oral cavity.”

By separating out the genetic differences between these clades, the researchers found that the tumor-infiltrating Fna C2 type had acquired distinct genetic traits suggesting it could travel from the mouth through the stomach, withstand stomach acid and then grow in the lower gastrointestinal tract. The analysis revealed 195 genetic differences between the clades.

Then, comparing tumor tissue with healthy tissue from patients with colorectal cancer, the researchers found that only the subtype Fna C2 is significantly enriched in colorectal tumor tissue and is responsible for colorectal cancer growth.

Further molecular analyses of two patient cohorts, including over 200 colorectal tumors, revealed the presence of this Fna C2 lineage in approximately 50% of cases.

The researchers also found in hundreds of stool samples from people with and without colorectal cancer that Fna C2 levels were consistently higher in colorectal cancer.

“We  have pinpointed the exact bacterial lineage that is associated with colorectal cancer, and that knowledge is critical for developing effective preventive and treatment methods,” Johnston said.

He and Bullman believe their study presents significant opportunities for developing microbial cellular therapies, which use modified versions of bacterial strains to deliver treatments directly into tumors.

###

Fred Hutchinson Cancer Center unites individualized care and advanced research to provide the latest cancer treatment options while accelerating discoveries that prevent, treat and cure cancer and infectious diseases worldwide.

Based in Seattle, Fred Hutch is an independent, nonprofit organization and the only National Cancer Institute-designated cancer center in Washington. We have earned a global reputation for our track record of discoveries in cancer, infectious disease and basic research, including important advances in bone marrow transplantation, immunotherapy, HIV/AIDS prevention and COVID-19 vaccines. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services. Fred Hutch also serves as UW Medicine’s cancer program.


Read More

Continue Reading

Spread & Containment

Fashion needs stronger storytelling that is more inclusive, relevant and responsible

Representing 2% of global GDP, the fashion industry must use its cultural reach to drive a shift towards a more sustainable and equitable industry.

Published

on

By

The fashion industry could not exist without storytelling. Compelling and aspirational stories conveyed through catwalks, campaigns and social media are the stuff that make garments fashionable, fostering a strong desire to be seen wearing them.

Fashion’s stories can spread positive messaging about issues that affect us all. In 2020, Stella McCartney’s Paris show featured models wearing cartoonish animal costumes. This humorous stunt emphasised a serious point about the “planet-friendly” brand’s pledge not to use leather, fur, skins, feathers or animal glues.

But more often, the darker, more unpalatable truth is that fashion’s storytelling drives overconsumption. And it defines unrealistic beauty expectations that exclude many by perpetuating western standards about what is normal and acceptable.

As a cultural historian who researches fashion, I believe the industry has to do better to effect change, and this can be achieved through stronger, more inclusive and responsible storytelling.

Fashion and world problems

According to recent fashion industry reports, storytelling is becoming more prominent as brands seek to demonstrate their social responsibility by forging deeper relationships with consumers. The increased significance of storytelling within fashion can be linked to two themes that have defined social and political debate about the world’s post-COVID recovery: self and society.

Consumers want more meaningful experiences that enable them to explore their identities and connect with others. Fashion is the ideal medium for this, especially during a time of social and political unease. The industry’s global reach means that visual cues and messaging conveyed through clothing campaigns can be easily shared and understood.

The Business of Fashion’s report, The State of Fashion 2024, links the increased importance of storytelling to consumers being “more demanding when it comes to authenticity and relatability”. People want to buy brands that share and support their values.

The consumer group most concerned to align their lifestyle choices and beliefs with the companies that clothe them is Gen-Z – people born between 1996 and 2010 – who “value pursuing their own unique identities and appreciate diversity”.

The increasing prominence of storytelling in fashion is also linked to the industry’s global sway and corresponding social responsibility. Organisations like the UN are increasingly clear that the fashion industry will only help tackle the global challenges emphasised by COVID if it uses its influence to change consumers’ mindsets.

The uneven social impact of the pandemic, which emphasised longstanding inequalities, provided a wake-up call to take action on many global problems, including climate change, overconsumption and racial discrimination. This makes the fashion industry, which contributes 2% to global GDP, a culprit but also a potential champion for driving change.

The British Fashion Council’s Fashion Diversity Equality & Inclusion Report, published in January 2024, highlights “fashion’s colossal power to influence, to provide cultural reference and guide social trends”. Similarly, the UN’s Fashion Communication Playbook, published last year, urges the industry to use its “cultural reach, powers of persuasion and educational role to both raise awareness and drive a shift towards a more sustainable and equitable industry”.

To do this, the UN’s report urges storytellers, imagemakers and role models to change the narrative of the fashion industry. They are asked to educate consumers and inspire them to alter their behaviour if it can help create positive change.

Fashion’s new stories

Since the pandemic, there is evidence the fashion industry has begun to change the content and form of the stories it tells, chiefly by putting a human face on current global challenges. Large-scale, entrenched social problems are being explored through real-life stories. This can help people to understand the problems that confront them, and grasp their role in working towards overcoming them.

One example is Nike’s Move to Zero campaign, a global sustainability initiative which launched during the pandemic in 2020. Instead of endless statistics and apocalyptic warnings about crisis-point climate emergency, Nike encourages people to “refresh” sports gear with maintenance and repair. Old Nike products that have been recreated by designers are sold through pop-ups. When salvage is not possible, Nike provides ways for people to recycle and donate old products.

By encouraging relatively small changes that align the lifecycle of a product with consumers’ everyday lives, Nike’s campaign challenges the traditional idea of clothes being new, immediate and ultimately disposable by making change aspirational.

Narrative hang-ups

While some fashion brands are rethinking the stories they tell, my recent book, Hang-Ups: Reflections on the Causes and Consequences of Fashion’s Western Centrism, explains that some of fashion’s most powerful and harmful stories are deep-rooted.

Concepts defined during the 18th and 19th centuries – civilisation, anthropology, sexology – still influence how the fashion industry engages with age, gender, race and sex. Its drive for newness and the way it pushes the idea that purchasing expensive brands brings automatic status is also based on traditional western social values that fit poorly with 21st-century perspectives and priorities.

The persistence of centuries-old attitudes is apparent too in Nike’s Move to Zero campaign, however well-intentioned. While the initiative is clearly conceived to influence consumer behaviour in a positive way, it still doesn’t fundamentally address what the fashion industry is and does. But at the very least, it accepts that fashion functions through high consumption and the sense of status that owning and wearing a brand confers.

Throwing everything out

One of the key points I make in my book is that effective change will be more likely if we understand how the industry developed into what it is today. This calls for more audacious storytelling that critiques notions of normality, acceptability and inclusivity.

One example is Swedish brand Avavav, which commits itself to “creative freedom driven by humour, entertainment and design evolution”. In February 2024, the brand’s Milan catwalk show concluded with models being pelted with litter. This experimental performance explored prevailing social media stories by calling out online trolls and highlighting the hurt of hate speech, within and beyond the fashion industry.

Naturally, it caused a sensation and was widely covered in the media. A stunt perhaps, but it got people talking and drew attention to designer Beate Karlsson’s message about online hate. Clearly, compelling and innovative storytelling has the power to change minds and behaviour.


Looking for something good? Cut through the noise with a carefully curated selection of the latest releases, live events and exhibitions, straight to your inbox every fortnight, on Fridays. Sign up here.


Benjamin Wild does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Read More

Continue Reading

Trending